A new branch of a national cancer charity has opened in the grounds of a town's hospital. The Maggie's Centre will offer ...

A targeted drug combination delays advanced prostate cancer in men with specific DNA repair gene mutations. A large international study led by researchers at UCL has found that a new combination of dr ...

Big pharmas unveil ADC and radiopharmaceutical phase 3 wins at ESMO Big pharmas report pivotal phase 3 wins for ADCs and ...

The evolution of immunotherapy, featuring CAR-T cells and senolytics, highlights potential in cancer treatment and challenges ...

As the government shutdown enters its fourth week, Senate Republicans are headed to the White House on Tuesday — not for ...

Breakthroughs in RNA editing and radioligand therapies are poised to take biotech into a new era – driving innovation, growth and new investment opportunities Biotechnology is entering a dynamic new ...

A new drug combination to treat advanced recurring prostate cancer has shown remarkable results in a long-term trial, ...

A spokesperson for Joe Biden says the former Democratic president has completed several weeks of radiation therapy to treat ...

A Biden spokeswoman confirmed the former president finished several weeks of radiation therapy treatment Monday.

“As part of a treatment plan for prostate cancer, President Biden is currently undergoing radiation therapy and hormone ...

Former President Joe Biden, who was diagnosed with an aggressive form of prostate cancer in May, completed a course of ...

An international research team led by the Medical University of Vienna has demonstrated for the first time that thyroid hormone plays a key role in the development and progression of prostate cancer.